SRStijn Raven

Stijn Raven

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stijn Raven has a total of 63 co-authors. Here are the top co-authors by number of shared publications:

  • Cornelia H. M. van Jaarsveld

    Department of Primary and Community Care, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands

    4 shared publications
  • Aura Timen

    Department of Primary and Community Care, Radboud University Medical Center, Geert Grooteplein Noord 21, Nijmegen, 6525EZ, The Netherlands, 31 0243618181

    3 shared publications
  • Babette van Deursen

    Department of Primary and Community Care, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands

    3 shared publications
  • Jim van Steenbergen

    Centre for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, The Netherlands

    3 shared publications
  • Christian Hoebe

    Department of Medical Microbiology, School of Public Health and Primary Care (CAPHRI), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands; Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Service, The Netherlands

    2 shared publications
  • Christian J P A Hoebe

    Department of Sexual Health, Infectious Diseases and Environmental Health, South Limburg Public Health Services, Heerlen, The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Data-Driven Infectious Disease Control: Qualitative Study of Professionals’ Attitudes, Barriers, and Needs

    by Babette van Deursen, Cornelia H M van Jaarsveld, Tessa van der Bruggen, Stijn Raven, Julie E M Swillens, Aura Timen

    Background: Data-driven strategies are increasingly integrated into infectious disease control (IDC), enabling professionals to act in a timely and proactive manner; however, their implementation requires alignment with professionals’ needs. Little is known about professionals’ views on data-driven IDC. Objective: This study aims to assess IDC professionals’ knowledge, attitudes, and perceptions toward working in a data-driven manner, as well as their needs, facilitators, and barriers. Methods: We conducted exploratory online focus group discussions (FGDs) with IDC professionals from the Public Health Services (PHSs) in the Netherlands. FGDs were organized by profession, followed by a final mixed-group session that included medical doctors, nurses, infection preventionists, epidemiologists, policy advisors, project leaders, and managers working in IDC. The topic guide was based on the Attitude-Social Influence-Efficacy model and the Consolidated Framework for Implementation Research, complemented with questions on current practices within the PHS related to data-driven work (DDW). Framework and thematic analyses were performed. Results: Between September 2024 and January 2025, nine FGDs were conducted with 36 IDC professionals. Five main themes emerged: (1) context of the work environment, (2) interpretation of DDW in the context of IDC, (3) added value of DDW, (4) views on team participation, and (5) perspectives on development and implementation. While participants mentioned that some data-driven strategies were already implemented within the PHS, they observed that data were not often translated into action. Attitudes toward DDW varied across participants, particularly regarding its definition, application in daily practice, the importance of data interpretation by professionals, results, implementation, and added value. Participation in DDW varied within teams and was influenced by role, interest, workload, time, knowledge, and willingness to change. Participants also identified various facilitators, barriers, and needs at the individual, process, and organizational levels, such as a national approach of data-driven IDC guided by a shared vision, defined role assignments, and clear protocols for data registration. Conclusions: In this study, IDC professionals generally expressed a positive attitude toward DDW but also identified several barriers and needs for future implementation. The limited translation of data into action was viewed as untapped potential. To support effective data-driven IDC, we recommend investing in a supportive work environment that promotes a clear, shared definition of DDW, including defined roles and responsibilities. By doing so, IDC professionals can shift from reactive to strategic, data-informed action and be better equipped future public health threats.

  • Open Access

    A “Pandemic-Proof” Methodology for Outbreak Detection Adapted From COVID-19’s Impact on Notifications of Infectious Diseases in the Netherlands: Surveillance Study

    by Babette van Deursen, Stijn Raven, Wolfer van Den Bosch, Cornelia H M van Jaarsveld, Aura Timen

    Background: Reporting of notifiable infectious diseases was overall impacted by the COVID-19 pandemic. This could affect disease surveillance and thus, outbreak detection, as it is based on historical data. For effective outbreak detection, it is crucial that communicable disease control professionals can rely on accurate and valuable alarm thresholds to ensure timely and adequate response to potential outbreaks. Objective: In this study, we take the first steps in the development of a methodology that adjusts for the impact of the COVID-19 pandemic on the number of notifications of notifiable infectious diseases and provides corrected alarm thresholds for outbreak detection. We identify which infectious diseases were affected by the COVID-19 pandemic, assess the duration of these effects, and explore potential correction methods to improve outbreak detection. Methods: We analyzed cases of 25 notifiable infectious diseases reported from 2015‐2023 in the Netherlands. Negative binomial regression was used to calculate the incidence rate ratios for each period: pre-COVID-19 pandemic, COVID 2020, COVID 2021, COVID 2022, and post-COVID-19 pandemic. To address the decrease in notifications during the COVID-19 pandemic, we tested 3 correction methods: (1) recoding COVID-19 years as missing; (2) imputing with the last pre-COVID-19 pandemic observation; and (3) imputing the historical moving average. Results: Between 2015‐2023, a total of 74,990 notifications were reported in the Netherlands, of which 9,836 notifications (13%) occurred during the COVID-19 pandemic. Malaria, typhoid fever, hepatitis A, meningococcal infection, paratyphoid fever, Q-fever, shigellosis, measles, mumps, and pertussis had significantly lower notifications during the COVID-19 pandemic, but the duration and magnitude of the effect differed among the infections. The effect of the COVID-19 pandemic on the notifications of malaria (incidence rate ratio [IRR] 0.17, 95% CI 0.08‐0.36) and typhoid fever (IRR 0.12, 95% CI 0.02‐0.55) was only seen in 2020, while the notifications for measles (IRR 0.34, 95% CI 0.15‐0.75) and pertussis (IRR 0.34, 95% CI 0.20‐0.60) were still significantly lower in the post-COVID-19 pandemic period. In addition, the newly calculated alarm thresholds showed a noticeable difference compared with the original unadjusted alarm thresholds. However, the variation among the 3 different corrected alarm thresholds was not substantial. Conclusions: During the COVID-19 pandemic, notifications of 10 infectious diseases declined significantly. The duration of this decline varied among infections, highlighting the need for pattern-specific adjustments. Our study demonstrates that accounting for the reduced notifications impacts alarm threshold calculations for outbreak detection. We therefore recommend amending the alarm thresholds to account for this impact to ensure reliable outbreak detection, so that communicable disease control professionals can act in a timely and data-driven manner. The next step in the development of the “pandemic-proof” methodology is to determine which correction method is most suitable. Further validation by communicable disease control professionals is essential to assess the applicability of the adjusted alarm thresholds for outbreak detection.


  • Open Access

    Rising scabies incidence and the growing burden on GPs: a retrospective longitudinal study

    by Saskia C van der Boor, Ines Figaroa, Annemarie A Uijen, Stijn Fh Raven, Cornelia Hm van Jaarsveld

    Background: Scabies cases are rising in several high-income European countries, but its true incidence remains unclear owing to its non-notifiable status. GPs play a key role in managing scabies, yet the impact on primary care is unknown. Aim: To assess the epidemiology and care burden of scabies-related episodes in general practice. Design & setting: A retrospective longitudinal study using pseudonymised data from Dutch GPs. Method: Data from five general practices, covering nearly 40 000 patients from 2014–2023, were analysed. Scabies-related episode incidence, time between scabies-related symptoms and first GP encounter (patient’s delay), time between first GP encounter and scabies diagnosis (doctor’s delay), and care burden were compared between two periods: 2014–2020 (low incidence) and 2021–2023 (high incidence). Results: In total, 1525 scabies-related episodes, including 4555 recorded encounters, were included. Between 2014 and 2023, the incidence increased from 99 to 1341 episodes per 100 000 patient-years, with encounters rising from 614 to 2438 per 100 000 patient-years between the two periods. The largest increase in encounters occurred in those aged 17–25 years ( P 28 days decreased from 26.4% to 14.3%. Scabies diagnoses during initial consultations improved from 84.9% to 92.3%. Encounters without interventions declined from 36.9% to 14.4%. Medical prescriptions and referrals per 100 000 patient-years increased. Conclusion: Our findings highlight an exponential increase in scabies-related episodes, significantly increasing the burden on general practices. Regions experiencing rising scabies incidence rates should prioritise public health interventions to curb transmission, which require a coordinated clinical and public health response.


  • Open Access

    Data-Driven Infectious Disease Control: Qualitative Study of Professionals’ Attitudes, Barriers, and Needs (Preprint)

    by Babette van Deursen, Cornelia H M van Jaarsveld, Tessa van der Bruggen, Stijn Raven, Julie E M Swillens, Aura Timen

    BACKGROUND Data-driven strategies are increasingly integrated into infectious disease control (IDC), enabling professionals to act in a timely and proactive manner; however, their implementation requires alignment with professionals’ needs. Little is known about professionals’ views on data-driven IDC. OBJECTIVE This study aims to assess IDC professionals’ knowledge, attitudes, and perceptions toward working in a data-driven manner, as well as their needs, facilitators, and barriers. METHODS We conducted exploratory online focus group discussions (FGDs) with IDC professionals from the Public Health Services (PHSs) in the Netherlands. FGDs were organized by profession, followed by a final mixed-group session that included medical doctors, nurses, infection preventionists, epidemiologists, policy advisors, project leaders, and managers working in IDC. The topic guide was based on the Attitude-Social Influence-Efficacy model and the Consolidated Framework for Implementation Research, complemented with questions on current practices within the PHS related to data-driven work (DDW). Framework and thematic analyses were performed. RESULTS Between September 2024 and January 2025, nine FGDs were conducted with 36 IDC professionals. Five main themes emerged: (1) context of the work environment, (2) interpretation of DDW in the context of IDC, (3) added value of DDW, (4) views on team participation, and (5) perspectives on development and implementation. While participants mentioned that some data-driven strategies were already implemented within the PHS, they observed that data were not often translated into action. Attitudes toward DDW varied across participants, particularly regarding its definition, application in daily practice, the importance of data interpretation by professionals, results, implementation, and added value. Participation in DDW varied within teams and was influenced by role, interest, workload, time, knowledge, and willingness to change. Participants also identified various facilitators, barriers, and needs at the individual, process, and organizational levels, such as a national approach of data-driven IDC guided by a shared vision, defined role assignments, and clear protocols for data registration. CONCLUSIONS In this study, IDC professionals generally expressed a positive attitude toward DDW but also identified several barriers and needs for future implementation. The limited translation of data into action was viewed as untapped potential. To support effective data-driven IDC, we recommend investing in a supportive work environment that promotes a clear, shared definition of DDW, including defined roles and responsibilities. By doing so, IDC professionals can shift from reactive to strategic, data-informed action and be better equipped future public health threats.

  • Circulation of avian Chlamydia abortus in the Netherlands and community-acquired pneumonia: an outbreak investigation and retrospective cohort study

    by Stijn Raven, Marloes Heijne, Jeroen Koomen, Gert Doornenbal, Miriam Maas, Pieter Jacobs, Ingrid Keur, Frederika Dijkstra, Daphne Reukers, Mark Platenburg, et al.


  • Contribution of sexual health services to hepatitis B detection and control (Netherlands, 2008–2016)

    by Stijn Raven, Jeannine Hautvast, Wing-Kee Yiek, Irene Veldhuijzen, Jim van Steenbergen, Fleur van Aar, Christian J P A Hoebe

    Objectives Case finding is one of the priority actions to reduce the disease burden of chronic hepatitis B (CHB). We estimated the contribution of CHB case finding at sexual health centres (SHCs) to the total national number of newly diagnosed CHB cases in the Netherlands and determined the characteristics of CHB cases detected at SHCs. Methods This observational study used surveillance data from all outpatient SHCs in the Netherlands (SOAP database) and the number of CHB from national notification data (Osiris) from 2008 to 2016. The proportion of CHB notifications (hepatitis B surface antigen positive serology) detected at SHCs was calculated. SHC consultations without hepatitis B virus (HBV) testing (n=669 308), with acute hepatitis B diagnosis (n=73), with HBV vaccination only (n=182) or an inconclusive hepatitis B diagnosis (n=24) were excluded. Univariable and multivariable logistic regression analyses were performed, stratified by gender and sexual preference, to analyse patient characteristics associated with CHB. Results During the study period, 12 149 CHB cases were notified. 405 646 SHC consultations were included in the analysis and 1452 CHB cases (0.4%) were detected at SHCs. The proportion of CHB cases detected at SHCs in relation to the national notified number ranged between 12.4% (200 of 1613) in 2008 and 10.8% (106 of 980) in 2016. 87% of CHB cases were among first-generation migrants (FGMs) originating from high endemic countries for sexually transmitted infections or men who have sex with men (MSM). In multivariable analysis, an older age category, migration background and being a commercial sex worker (CSW) were associated with CHB in all stratified analyses. Conclusions The contribution of SHCs is relevant to case finding of CHB in the Netherlands. SHCs should therefore be considered as an important health setting to screen for HBV in high-risk groups, especially among MSM, CSW and FGM, to achieve a reduction in the HBV-related disease burden.


  • Open Access

    Evaluation of a personalized, dose-sparing revaccination strategy in hepatitis B vaccine non-responders

    by Christian Beulens, Stijn F.H. Raven, Cornelia H.M. van Jaarsveld, Inge van Loo, Greet Boland, Leo G. Visser, Christian J.P.A. Hoebe, Ann C.T.M. Vossen


  • Open Access

    Epidemiological evaluation of mass testing in a small municipality in the Netherlands during the SARS-CoV-2 epidemic

    by Lisanne Heijmink, Juul Tönis, Niek Gilhuis, Maartje Gerkema, Lotte Hart, Stijn Raven, Jossy van Den Boogaard, Agnetha Hofhuis, Susan van Den Hof, Olga Visser

    During 6 weeks in February–March 2021, the Dutch municipal health service Utrecht studied the epidemiological effects on test incidence and the detection of acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with mass testing (MT). During MT, inhabitants of Bunschoten could repeatedly test regardless of symptoms and as often as desired at the close-by test facilities in the municipality. Data from the regular COVID-19 registration was used for analysis. In Bunschoten, MT caused a significant increase in test incidence and an immediate increase in the number of detected active infections, in contrast to a stabilisation in the rest of the province of Utrecht. Age distribution of test incidence shifted to the older population in Bunschoten during MT. During MT, there was a 6.8 percentage point increase in detected asymptomatic cases, a 0.4 percentage point increase in pre-symptomatic cases and a decrease of 0.5 days between onset of symptoms and test date. This study has shown that MT increases test incidence and helps to obtain a more complete view of the presence of SARS-CoV-2 in a community, which can be useful in specific situations with a defined target group or goal. However, the question remains open whether the use of MT is proportionate to the overall gain.


  • Only one serological assessment is sufficient to determine the need for hepatitis B revaccination in non-responders

    by Stijn F.H. Raven, Jeannine L.A. Hautvast, Christian J.P.A. Hoebe